These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 25103255)

  • 1. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
    Mitragotri S; Burke PA; Langer R
    Nat Rev Drug Discov; 2014 Sep; 13(9):655-72. PubMed ID: 25103255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.
    Cun D; Wan F; Yang M
    Curr Pharm Des; 2015; 21(19):2599-610. PubMed ID: 25876915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
    Batchelor HK; Kendall R; Desset-Brethes S; Alex R; Ernest TB;
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):833-42. PubMed ID: 23665448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
    Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
    Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
    Gukasyan HJ; Hailu S; Karami TK; Graham R
    Drug Discov Today; 2019 Aug; 24(8):1587-1597. PubMed ID: 30959112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated early formulation strategy--from hit evaluation to preclinical candidate profiling.
    Maas J; Kamm W; Hauck G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):1-10. PubMed ID: 17123801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin-based pharmaceutics: past, present and future.
    Davis ME; Brewster ME
    Nat Rev Drug Discov; 2004 Dec; 3(12):1023-35. PubMed ID: 15573101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying.
    Wan F; Yang M
    Int J Pharm; 2016 Feb; 498(1-2):82-95. PubMed ID: 26688034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances on self modified patch for (trans) dermal drug delivery.
    Pandey S; Patil A
    Recent Pat Drug Deliv Formul; 2015; 9(1):88-94. PubMed ID: 24981287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in abuse-deterrent technologies for the delivery of opioids.
    Maincent J; Zhang F
    Int J Pharm; 2016 Aug; 510(1):57-72. PubMed ID: 27291971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.
    Mandal A; Pal D; Agrahari V; Trinh HM; Joseph M; Mitra AK
    Adv Drug Deliv Rev; 2018 Feb; 126():67-95. PubMed ID: 29339145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexibility--the guiding principle for antibody manufacturing.
    Carson KL
    Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric delivery systems for biopharmaceuticals.
    Dinarvand R; Dorkoosh F; Hamidi M; Moghadam SH
    Biotechnol Genet Eng Rev; 2004; 21():147-81. PubMed ID: 17017031
    [No Abstract]   [Full Text] [Related]  

  • 15. Formulation aspects in the development of osmotically controlled oral drug delivery systems.
    Verma RK; Krishna DM; Garg S
    J Control Release; 2002 Feb; 79(1-3):7-27. PubMed ID: 11853915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular PEGylation of biopharmaceuticals.
    Webber MJ; Appel EA; Vinciguerra B; Cortinas AB; Thapa LS; Jhunjhunwala S; Isaacs L; Langer R; Anderson DG
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14189-14194. PubMed ID: 27911829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.
    Kirkby M; Hutton ARJ; Donnelly RF
    Pharm Res; 2020 Jun; 37(6):117. PubMed ID: 32488611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide conjugation chemistry: a mixed blessing for therapeutic drug delivery?
    Danial M; Postma A
    Ther Deliv; 2017 Jun; 8(6):359-362. PubMed ID: 28530144
    [No Abstract]   [Full Text] [Related]  

  • 19. Europe's emerging biopharmaceutical companies.
    Clark CR; Walton F
    Biotechnology (N Y); 1992 Oct; 10(10):1108-10. PubMed ID: 1368790
    [No Abstract]   [Full Text] [Related]  

  • 20. QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.
    Singh B; Kaur A; Dhiman S; Garg B; Khurana RK; Beg S
    AAPS PharmSciTech; 2016 Apr; 17(2):454-65. PubMed ID: 26238805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.